Neoplasms: all 9,616 studies
Page 75 of 97. Open to participants first (2,508), then studies with results posted, then the rest; newest registration first within each.
- Profile Related Evidence to Determine Individualized Cancer Therapy (PREDICT) Program in Advanced Cancer PatientsStatus unknownNCT02160366
- First in Human Dose Escalation Study of Vactosertib (TEW-7197) in Subjects With Advanced Stage Solid TumorsCompletedNCT02160106Phase 1
- Lower Dose Decitabine (DAC)-Primed TC (Carboplatin-Paclitaxel) Regimen in Ovary CancerStatus unknownNCT02159820Phase 2/3
- Prospective Follow-up of Outcomes in Patients Receiving Photodynamic Therapy for Neoplastic DiseasesActive, not recruitingNCT02159742
- Cytoreductive Surgery (CRS) With/Without HIPEC in Gastric Cancer With Peritoneal CarcinomatosisCompletedNCT02158988Phase 3
- Redosing With CP-870, 893 in Patients With Clinical Benefit After a Single Infusion From A Phase I, Open-Label, Dose-Escalation Study of CP-870,893 in Patients With Solid TumorsCompletedNCT02157831Early Phase 1
- M6620 First in Human StudyCompletedNCT02157792Phase 1
- Lymph Node Involvement Using Extended Pelvic Lymphadenectomy in Clinically Localized Prostate CancerCompletedNCT02156414
- Enteral Feeding in Discharged PatientsTerminatedNCT02155140Not applicable
- Pharmacokinetics of Tivantinib in Subjects With Advanced Solid Tumors and Hepatic ImpairmentCompletedNCT02150733Phase 1
- Acupuncture for Unintentional Weight Loss and Anorexia With GI CancerCompletedNCT02148159Not applicable
- A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic CancerCompletedNCT02146313Phase 1
- A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid TumorsCompletedNCT02145559Phase 1
- Study to Determine and Evaluate a Safe and Tolerated Dose of HDM201 in Patients With Selected Advanced Tumors That Are TP53wtCompletedNCT02143635Phase 1
- Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid TumorsCompletedNCT02143401Phase 1
- N-of-1 Trial: Actionable Target Identification in Metastatic Cancer for Palliative Systemic TherapyCompletedNCT02142036Phase 2
- Microbiome Test for the Detection of Colorectal Polyps and CancerCompletedNCT02141945
- Ph1 to Assess Safety, Tolerability of Tremelimumab/ Tremelimumab+MEDI4736 in Japanese Solid Malignancies/ MesotheliomaCompletedNCT02141347Phase 1
- Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial NeoplasiaCompletedNCT02139267Phase 2
- Serial FLT PET Imaging in Cancer Patients for Monitoring of Response to TherapyWithdrawnNCT02139150Not applicable
- Phase I Dose Escalation of Oral BAY1161909 in Combination With Intravenous PaclitaxelTerminatedNCT02138812Phase 1
- A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder CancerActive, not recruitingNCT02138734Phase 1/2
- Phase 1 Trial of Chlorogenic Acid in Patients With Advanced CancerTerminatedNCT02136342Phase 1
- Dose-escalating, Safety, Tolerability and PK Study of TAS-119 in Combination With Paclitaxel in Patients With Advanced Solid TumorsTerminatedNCT02134067Phase 1
- A Psychosocial Intervention Plus Early Palliative Care in the Reduction of Depression of Advanced Cancer PatientsTerminatedNCT02133274Not applicable
- Phase I Study of Sulfatinib(HMPL-012) in Patients With Advanced Solid TumorsCompletedNCT02133157Phase 1
- Next Generation Sequence Target-Directed Therapy in Treating Patients With CancerCompletedNCT02132845Not applicable
- A Study of Lapatinib in Combination With Caelyx in Patients With Advanced HER2 Positive Pretreated Breast CancerTerminatedNCT02131506Phase 1
- A Pilot Study Treatment of Malignant Tumors Using [18F] Fluorodeoxyglucose (FDG)SuspendedNCT02130492Phase 1/2
- Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the CervixCompletedNCT02130323Phase 2/3
- Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic MalignanciesCompletedNCT02129582Phase 1
- Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their ChildrenCompletedNCT02129049Not applicable
- Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric CancerCompletedNCT02128243Phase 2
- A Study of Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow DisordersCompletedNCT02125318Phase 2
- A Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Participants With Advanced CancerCompletedNCT02124148Phase 1
- Identification of Risk Factors Associated With Neoplastic Complications After Renal Transplantation in Nord-Pas de Calais , Normandy and Picardy RegionsCompletedNCT02121730
- Treg Cells for AGVHD in Non-myeloablative UCB TransplantWithdrawnNCT02118311Phase 2
- Efficacy of a Patient Education VideoTerminatedNCT02114827Not applicable
- Tumor Kinase Inhibitor Concentrations Measured by PETCompletedNCT02111889Not applicable
- A Multimodality Image-guided System for Peripheral Lung Cancer Diagnosis and TherapyTerminatedNCT02111824Phase 1
- Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or LymphomaTerminatedNCT02110563Phase 1
- A Phase 1b/2a Study Evaluating AMG 232 in Metastatic MelanomaCompletedNCT02110355Phase 1
- Analysis of Tumor Tissue and Circulating Genetic Material in the Blood to Obtain Further Insight in the Effectiveness of Everolimus When Combined With ExemestaneStatus unknownNCT02109913Not applicable
- Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With CancerCompletedNCT02108028
- The Palliative Radiotherapy And Inflammation Study - PRAISCompletedNCT02107664
- Effect of Regorafenib on Digoxin and Rosuvastatin in Patients With Advanced Solid Malignant Tumors.CompletedNCT02106845Phase 1
- Photodynamic Therapy During Surgery in Treating Patients With Pleural MalignancyWithdrawnNCT02106559Not applicable
- NaF PET/MRI Evaluation for Bone Metastases in Breast CancerCompletedNCT02103634
- Covered Versus Uncovered Biliary Stents for Biliary MalignanciesCompletedNCT02102984Not applicable
- Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular CarcinomaTerminatedNCT02102022Phase 1/2
- Safety and Efficacy of GX-188E DNA Therapeutic Vaccine Administered by Electroporation After ObservationStatus unknownNCT02100085
- A Study Evaluating the Safety, Pharmacokinetics (PK), and Preliminary Efficacy of ABBV-399 in Participants With Advanced Solid TumorsActive, not recruitingNCT02099058Phase 1
- Regorafenib and Cetuximab in Patients With Advanced MalignancyCompletedNCT02095054Phase 1
- rTMS as a Treatment of Visceral Pain Secondary to MalignancyCompletedNCT02092805Not applicable
- Perioperative FOLFIRI VS Adjuvant FOLFIRI in Resectable Advanced CRC Failed to OxaliplatinStatus unknownNCT02087475Phase 3
- HPV (Human Papilloma Virus) Vaccination After Treatment of Anal Intraepithelial Neoplasia (AIN)CompletedNCT02087384Phase 4
- Phase I Clinical Study Combining L19-IL2 With SABR in Patients With Oligometastatic Solid TumorCompletedNCT02086721Phase 1
- A Phase I Dose Finding Study in Children With Solid Tumors Recurrent or Refractory to Standard TherapyCompletedNCT02085148Phase 1
- Study of Molecular and Genetic Abnormalities in Patients With Myeloid NeoplasmsCompletedNCT02084563Phase 2
- Clinical Trials Education Program for Hispanic AmericansCompletedNCT02083770Phase 3
- HIPEC For Peritoneal Surface Malignancies Including Carcinomatosis or Sarcomatosis - Data RegistryCompletedNCT02082886
- Tailoring Patient Education to Perceived Risk for Falls in Hospitalized Oncology PatientsCompletedNCT02081794Not applicable
- A Study of DOXIL/CAELYX in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian CancerCompletedNCT02081495Phase 1
- 18F-FMAU PET/CT in Imaging Patients With Advanced CancersTerminatedNCT02079181Not applicable
- Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study.CompletedNCT02078700Phase 2
- rTMS as a Treatment of Neuropathic Pain Secondary to MalignancyCompletedNCT02078479Not applicable
- Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic TumorsCompletedNCT02077933Phase 1
- MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid TumorsCompletedNCT02076906Phase 1
- Study of Combination Ruxolitinib and Decitabine Treatment for Accelerated Phase MPN or Post-MPN AMLCompletedNCT02076191Phase 1/2
- Study of the Glutaminase Inhibitor CB-839 in Solid TumorsCompletedNCT02071862Phase 1
- Chloroquine in Combination With Carboplatin/Gemcitabine in Advanced Solid TumorsCompletedNCT02071537Phase 1
- Trametinib in Treating Patients With Advanced Cancer With or Without Hepatic DysfunctionCompletedNCT02070549Phase 1
- A Study of Drug Therapies for Salivary Gland Cancers Based on Testing of GenesCompletedNCT02069730Not applicable
- Genetics in Predicting Risk of Bisphosphonate-Related Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic AcidWithdrawnNCT02069340Not applicable
- Association Between Confocal Laser Endomicroscopic (CLE) Features and Gastric Mucosal MicrobiomeStatus unknownNCT02063932
- Study of High-dose, Intermittent Sunitinib in Patients With Solid Tumors.CompletedNCT02058901Phase 1
- Endoscopic Evaluation of Premalignant Lesions in the Biliary Tract and Pancreatic DuctsCompletedNCT02057146Not applicable
- PAZOFOS: Phase Ib and Phase II Trial of Pazopanib +/- Fosbretabulin in Advanced Recurrent Ovarian CancerTerminatedNCT02055690Phase 1/2
- Study of Current Practice Which Compare the Rate of Prostate Cancer by Using 2 Kind of Transrectal Biopsies: 3 by IRM-echography Image Fusion and 12 Systematized Guided Echographies.CompletedNCT02050542Not applicable
- A Study of Vintafolide (MK-8109) in Participants With Advanced Solid Tumor (MK-8109-011)TerminatedNCT02049281Phase 1
- Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Advanced Solid TumorsCompletedNCT02048709Phase 1
- Safety of Romiplostim (Nplate®) Following UCBTCompletedNCT02046291Phase 1
- Phase II Clinical Trial of Uncaria Tomentosa (Cat´s Claw) in Patients With Advanced Solid TumorsStatus unknownNCT02045719Phase 2
- Phase I Dose Escalation Study of Intravenous VCN-01 With or Without Gemcitabine and Abraxane® in Patients With Advanced Solid TumorsCompletedNCT02045602Phase 1
- Monitoring of Oral Human Papillomavirus Infection (HPV) in HPV-positive Oropharyngeal Squamous Cell Carcinoma (OPSCC)TerminatedNCT02045186Not applicable
- Intraductal Papillary Mucinous Neoplasm With Malignant ChangeTerminatedNCT02044926
- Phase 1 Safety Study of ACT-PFK-158, 2HCl in Patients With Advanced Solid MalignanciesStatus unknownNCT02044861Phase 1
- Current Practice Pattern and Effect of Training in Upper Endoscopic BiopsyCompletedNCT02044536
- Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVRCompletedNCT02043184Not applicable
- MLN9708 and Vorinostat in Patients With Advanced p53 Mutant MalignanciesCompletedNCT02042989Phase 1
- Study of the Safety and Tolerability of IV Infused PG545 in Patients With Advanced Solid TumoursCompletedNCT02042781Phase 1
- Awareness and Attitude of Cancer Patients About Participation in Clinical Research (CR) in Saudi ArabiaCompletedNCT02042469
- Safety and Effectiveness of RegorafenibCompletedNCT02042144
- Interest of PReOPerative Immunonutrition in Liver Surgery for CancerCompletedNCT02041871Not applicable
- Technology to Assess Vulnerable Older Adults With Cancer and Their CaregiversActive, not recruitingNCT02041416
- Serum Cholesterol and Gastric NeoplasmStatus unknownNCT02041312
- Trial to Study the Safety of Intravenous MNK-010 in Advanced Solid TumorsTerminatedNCT02040558Phase 1
- 68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine TumorsStatus unknownNCT02038738Phase 1/2
- An Open-label Phase I Study of Orally Available Novel Small-molecule Fibroblast Growth Factor Receptors (FGFR) 1,2,3 and 4 Inhibitor, ASP5878 at Single and Multiple Doses in Patients With Solid TumorsCompletedNCT02038673Phase 1
- Quality of Life of Patients With Colorectal Neoplasm and Cost-Effectiveness Analysis of Colorectal Cancer ScreeningCompletedNCT02038283